Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After Whipple's (RAW) study.
Rajagopalan A, Aroori S, Russell TB, Labib PL, Ausania F, Pando E, Roberts KJ, Kausar A, Mavroeidis VK, Marangoni G, Thomasset SC, Frampton AE, Lykoudis P, Maglione M, Alhaboob N, Bari H, Smith AM, Spalding D, Srinivasan P, Davidson BR, Bhogal RH, Dominguez I, Thakkar R, Gomez D, Silva MA, Lapolla P, Mingoli A, Porcu A, Shah NS, Hamady ZZR, Al-Sarrieh B, Serrablo A, Croagh D; RAW Study Collaborators.
Rajagopalan A, et al. Among authors: shah ns.
HPB (Oxford). 2024 Apr 26:S1365-182X(24)01276-0. doi: 10.1016/j.hpb.2024.04.010. Online ahead of print.
HPB (Oxford). 2024.
PMID: 38755085
This study examines the impact of preoperative DM, both recent-onset and pre-existing, on long-term outcomes following pancreatoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC). ...
This study examines the impact of preoperative DM, both recent-onset and pre-existing, on long-term outcomes following pancreatoduode …